{"id":"W2106082064","doi":"10.1016/j.clml.2015.07.649","title":"Novel Therapies for Chronic Lymphocytic Leukemia: A Canadian Perspective","year":2015,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; University of Toronto; Jewish General Hospital; McGill University; BC Cancer Agency; Princess Margaret Cancer Centre; Foothills Medical Centre","funders":"","keywords":"Ibrutinib; Obinutuzumab; Venetoclax; Idelalisib; Chemoimmunotherapy; Chronic lymphocytic leukemia; Fludarabine; Medicine; Rituximab; Ofatumumab; Oncology; Internal medicine; Cyclophosphamide; Bendamustine; Leukemia; Immunology; Lymphoma; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004245972,0.002466183,0.009347534,0.001464277,0.0005851364,0.0003310652,0.002299979,0.004594964,0.0003240441],"category_scores_gemma":[0.005755268,0.002052716,0.004907114,0.001911199,0.001940009,0.0003115473,0.0006593718,0.001837242,0.002255976],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.7930896,"about_ca_system_score_gemma":0.7726949,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.132945,"about_ca_topic_score_gemma":0.02439396,"domain_scores_codex":[0.9857101,0.0006470031,0.004313651,0.003694861,0.001915287,0.003719059],"domain_scores_gemma":[0.9835171,0.004227197,0.001377979,0.003853879,0.002348047,0.004675793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004799847,0.0001010808,0.00000175286,0.01304281,0.002596284,0.001244822,0.000233762,0.0000108268,9.158309e-7,0.002029042,0.02783849,0.9524202],"study_design_scores_gemma":[0.03285981,0.001755832,0.0001182589,0.01261743,0.00491882,0.006576729,0.0002307846,0.003124214,0.000002230555,0.0005973419,0.9353019,0.001896625],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002443994,0.9776943,0.0001534796,0.0001990617,0.002136116,0.008154573,0.0009178466,0.0005205533,0.009979726],"genre_scores_gemma":[0.0004055511,0.9766743,0.00186915,0.0009517738,0.007400175,0.002229157,0.001138272,0.0009266132,0.008405024],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9505236,"threshold_uncertainty_score":0.9988075,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1468459377124565,"score_gpt":0.4434761803015968,"score_spread":0.2966302425891403,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}